Tag: Study
-
Opella: New study demonstrates successful cough treatment extends beyond symptom relief
PARIS, Oct. 15, 2026 /PRNewswire/ — A new real-world study from Opella, the maker of Mucosolvan and Bisolvon, provides pharmacists with compelling evidence that the success of a cough treatment should be measured by its impact on a patient’s overall well-being, alongside traditional symptomatic rel…
-
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
SHANGHAI, Oct. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to…
-
IBM Study: As AI Scales Enterprise-Wide, CFOs Play an Expanded Role in Transformation
Most CFOs report their role has expanded into enterprise technology or AI strategy leadershipBy 2030, more than half of surveyed CFOs expect to help design financial and ethical guardrails for AIARMONK, N.Y., Sept. 30, 2026 /PRNewswire/ — A new global study from the IBM (NYSE: IBM) Institute for Bu…
-
India's Biggest CX Benchmark Just Got Bigger: Twimbit, Nasscom and Kyndryl Set to Launch The State of CX India 2026, Benchmarking 500 Companies Across India
MUMBAI, India, Sept. 29, 2026 /PRNewswire/ — After putting India’s CX performance at 3.17 out of 5 in 2025, Twimbit, Nasscom and Kyndryl are expanding the study to 500 companies to understand what has changed and where customer experience still has room to improve. …
-
Companies Of The UN Global Compact Across Europe Make Tangible Contributions To The Sustainable Development Goals But Still Lack Operational Actions To Advance Environmental Goals
Release of the first comprehensive analysis of the private sector’s contribution to the 2030 agendaNEW YORK, Sept. 25, 2026 /PRNewswire/ — On the occasion of the United Nations General Assembly, UN Global Compact Networks Bulgaria, Finland, France, Germany, Italy, the United Kingdom and Türkiye are…
-
Hylenr Completes Phase 1 LCF Reactor Validation at Texas A&M University
Phase 1 testing identified key thermal, noble-gas and material signatures in the Lattice Confinement Fusion (LCF) reactor, with Hylenr now advancing to Phase 2 studies focused on reproducibility, quantitative measurement and commercialization.HYDERABAD, India, Sept. 22, 2026 /PRNewswire/ — Hyderaba…
-
Merry Life Biomedical Advances Global Phase 2 Trial of TML-6, Exploring Cellular Protein Clearance in Early Alzheimer's Disease
Global study brings together nine Taiwan medical centers, seven Swedish sites, and four U.S. centers to evaluate an oral therapy focused on autolysosomal biologyTAIPEI, Sept. 22, 2026 /PRNewswire/ — Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed investigational o…
-
New IBM CHRO Study: AI Puts Critical Thinking at the Center of Workforce Priorities
60% of employees worry AI is eroding their skills, with critical thinking cited most often as decliningNearly half of organizations do not involve the CHRO when AI strategy is being definedARMONK, N.Y., Sept. 21, 2026 /PRNewswire/ — A new global study from the IBM (NYSE: IBM) Institute for Business…
-
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline
ALCOR Scientific’s iSED® analyzers reshape lab logistics and improve patient care for one of medicine’s most widely used testsSeven times longer stability, independently validated. ESR samples on ALCOR Scientific’s iSED analyzer remained accurate for up to 28 hours at room temperature and 48 hours r…
-
LANDMARK GLOBAL STUDY REVEALS CRITICAL INEQUITIES IN ACCESS TO DERMATOLOGICAL CARE
First comprehensive global assessment by the International League of Dermatological Societies (ILDS) and L’Oréal Dermatological Beauty spans 158 countries and 97% of the world’s population.Summary: The Global Access to Skin Health Observatory Study, published in JAMA Dermatology, examines the distri…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.